The present invention relates generally to surgical equipment. More particularly, the present invention relates to apparatus, systems, and methods for introducing the sharp tip of a transseptal guidewire into a lumen of a transseptal needle while inhibiting contact between the sharp tip of the transseptal guidewire and the hub of the transseptal needle.
Guidewires are typically used to navigate catheters. For example, U.S. Patent Application Publication No. 2004/0073141 describes a guidewire that assists with endovascular deployment. The guidewire has a J curve and atruamatic tip to prevent damage to tissue. Introducers can be used to straighten the tips of such guidewires. For example, U.S. Pat. Nos. 5,125,905 and 5,282,479 relate to a guidewire straightener and protective tube to introduce a catheter into a patient's blood vessel.
Transseptal introducer systems are typically used to introduce Brockenbrough needles or other puncture devices into the heart of a patient to perforate the intra-atrial septum. For example, a transseptal guidewire is described in U.S. patent application Ser. No. 11/875,365, which is incorporated herein in its entirety by reference. The transseptal guidewire differs from conventional guidewires at least in that it has a tip that is sharp enough to puncture the septum, thereby providing a puncture device. Although the transseptal guidewire represents an improvement over prior puncture devices, damage to the sharp tip of the transseptal guidewire could render it unsuitable for use or require the surgeon to apply extra force to puncture the intra-atrial septum. For example, the sharp tip of the transseptal guidewire may be inadvertently damaged as it is introduced into the lumen of a transseptal needle through a hub of the needle or may be difficult to introduce into the lumen of the transseptal needle.
Accordingly, there remains a need for an apparatus, system and method for introducing the sharp tip of a transseptal guidewire into a lumen of a transseptal needle while inhibiting damage to the sharp tip of the transseptal guidewire.
In one aspect, the invention provides an apparatus for introducing a sharp tip of a transseptal guidewire through a hub of a transseptal needle and into a lumen of a transseptal needle while inhibiting damage to the sharp tip of the transseptal guidewire. The apparatus includes a holder configured to contain the transseptal guidewire and a shield coupled to the holder. The shield has a wall defining a lumen sized to accommodate the sharp tip of the transseptal guidewire. The cross-sectional shape of the wall is substantially constant along at least a portion of its length and is sized to fit within the lumen of the transseptal needle, thereby inhibiting contact between the sharp tip of the transseptal guidewire and the hub of the transseptal needle when the wall of the shield is positioned to extend into the lumen of the transseptal needle. The lumen of the shield has a substantially constant cross-sectional area along at least a portion of its length between proximal and distal ends of the shield, thereby facilitating insertion of the sharp tip of the transseptal guidewire through the lumen of the shield. An outer surface of the wall of the shield is cylindrical along at least a portion of its length between the proximal and distal ends of the shield, thereby facilitating insertion of the shield through the lumen of the transseptal needle to a point distal of the needle's hub and/or eliminating resistance between an outer surface of the shield and the inner surface of the lumen of the transseptal needle.
In another aspect, a system for perforating an intra-atrial septum is provided. The system includes a transseptal needle having proximal and distal ends, a hub positioned at the proximal end, and a lumen extending from the hub to the distal end. The system also includes a transseptal guidewire having a sharp tip sized to extend through the lumen of the transseptal needle. A holder at least partially contains the transseptal guidewire, and a shield is coupled to the holder. The shield has a wall defining a lumen sized to accommodate the sharp tip of the transseptal guidewire. The transseptal guidewire has a retracted position in which the sharp tip of the transseptal guidewire is contained within the lumen of the shield and an extended position in which the sharp tip of the transseptal guidewire extends distally from the shield and into the lumen of the transseptal needle. The shield has a first position in which the distal end of the shield does not extend into the lumen of the transseptal needle and a second position in which the distal end of the shield extends into the lumen of the transseptal needle to a position that is distal of the hub of the transseptal needle. The transseptal guidewire is in the retracted position when the shield is in the first position, and the transseptal guidewire is moved to the extended position when the shield is in the second position, thereby inhibiting contact between the sharp tip of the transseptal guidewire and the hub of the transseptal needle or the proximal end of the transseptal needle when the shield is in the second position.
According to yet another aspect, a method of shielding a sharp tip of a transseptal guidewire as it is introduced into a transseptal needle from a dispenser is provided. The method includes inserting a tip of a shield of the dispenser through a hub of the transseptal needle and into a lumen of the transseptal needle. The tip of the shield is then advanced to a point in the lumen distal of the hub without restriction. The sharp tip of the transseptal guidewire is introduced from a lumen of the shield of the dispenser and into the lumen of the transseptal needle at the point in the lumen distal of the hub, thereby avoiding contact between the sharp tip of the transseptal guidewire and the hub of the transseptal needle or a proximal end of the transseptal needle and associated damage to the sharp tip of the transseptal guidewire.
The invention is best understood from the following detailed description when read in connection with the accompanying drawings, with like elements having the same reference numerals. This emphasizes that according to common practice, the various features of the drawings are not drawn to scale. On the contrary, the dimensions of the various features are arbitrarily expanded or reduced for clarity. Included in the drawings are the following figures:
Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the invention.
Referring generally to the drawings (
According to another aspect of the invention, an exemplary embodiment of a method for shielding a sharp tip 29 of a transseptal guidewire 20 as it is introduced into a transseptal needle 80 is provided. The tip 2 of the shield 110 is inserted through the hub 60 and into the lumen 81 of the transseptal needle 80. The tip 2 of the shield 110 is then advanced to a point in the lumen 81 distal of the hub 60 without restriction. The sharp tip 29 of the transseptal guidewire 20 is introduced from the lumen 115 of the shield 110 of the dispenser 100 and into the lumen 81 of the transseptal needle 80 at the point in the lumen 81 distal of the hub 60, thereby avoiding contact between the sharp tip 29 of the transseptal guidewire 20 and the hub 60 of the transseptal needle 80 or a proximal end of the transseptal needle 80 and associated damage to the sharp tip 29 of the transseptal guidewire 20.
Referring now to the drawings in detail,
As shown in
A portion of end section 26 is ovalized such that end section 26 has a substantially non-circular cross section. Portion 24, however, has a substantially circular cross section relative to end section 26. In one embodiment, portion 24 is an imagable section having at least one radiopaque marker 25. Further details of transseptal guidewire 20 and methods for using transseptal guidewire 20 are described in U.S. patent application Ser. No. 11/875,365, which is incorporated herein in its entirety by reference.
Referring again to
According to an exemplary embodiment, holder 150 may be made out of a polymer or co-polymer such as high-density polyethene, low-density polyethylene, polyetherblockamide, nylon, polystyrene, or other suitable plastic material. The preferred material is high-density polyethylene. In other embodiments, holder 150 may be made out of any material that can be easily sterilized such as by the application of heat, chemicals, or irradiation prior to packaging or use before surgery. After surgery, it is contemplated that the entire dispenser 100 and guidewire 20 may be disposed, but the dispenser 100 and/or guidewire 20 can also be configured for sterilization and reuse.
Referring now to
According to an exemplary embodiment, shield 110 may be flexible so it may be manipulated for insertion into the lumen 81 of the transseptal needle 80 or so that it may be bent in a packaged or stored configuration (
As further illustrated in
As shown in
Referring again to
As mentioned above, transseptal guidewire 20 includes an elongated body 22, an end section 26, and a tapered distal section 28. The tapered distal section 28 terminates at the pointed tip 29 at the distal end of transseptal guidewire 20. In an exemplary embodiment, when transseptal guidewire 20 is positioned fully within shield 110, transseptal guidewire 20 retains a substantially straight configuration. When transseptal guidewire 20 extends through the distal end of shield 150 along longitudinal axis A-A (
As also illustrated in
Referring now to
Shield 110 is attached to extension 122 by adhesive, heat bond, ultrasonic bond, or other attachment means, depending on the materials of the shield 110 and the handle component 120. As described above, handle component 120 is optionally die cut from a sheet of material such as a polymeric material, vacuum formed, molded, or produced in other known manners. It is then folded in half about the holder 150 along the broken horizontal lines shown in
Referring now to
Referring specifically to
Referring now to
Referring now to
According to an embodiment, when shield 110 is inserted within hub 60, an annular recess 63 exists between the outer surface of shield and the inner surface of the hub 60. Hub 60 has shoulder 61a, 61b that facilitates the insertion of shield 110 into a portion of the transseptal needle lumen 81. While shoulders 61a, 61b provide transitions between interior regions of the hub 60 and the proximal end of the constant cross-sectional lumen 81 of the needle, such shoulders 61a, 61b may bind the sharp tip 29 of the transseptal guidewire 20 (especially if the tip 29 is at the terminal end of a J tip).
According to an exemplary embodiment, when the distal tip 2 of shield 110 contacts shoulders 61a, 61b, the distal tip of shield 110 is guided past shoulder 61a, 61b and into the lumen 81 of transseptal needle 80. As the sharp tip 29 of transseptal guidewire 20 is advanced beyond the distal tip 2 of shield 110 and into the lumen 81 of the transseptal needle 80, damage to the sharp tip 29 of transseptal guidewire 20 is inhibited or prevented.
As further illustrated in
Without shield 110, it is contemplated that proper insertion of a J-shaped transseptal guidewire 20 into the lumen of transseptal needle 80 would damage the sharp tip 29. Similarly, in an embodiment with a substantially straight guidewire 20, when the sharp tip 29 of guidewire 20 contacts shoulders 61a and/or 61b, it is contemplated that the sharp tip 29 may be damaged and thus, render the guidewire 20 unusable. It is also contemplated that the dispenser assembly 100 can be used with a needle that does not have a shoulder in a transition between a hub and a lumen. Even without such a shoulder, the shield of the dispenser facilitates introduction of the transseptal guidewire into the lumen of the needle.
Referring now to
Although an exemplary embodiment of shield 110 in the form of a cylindrical tube is illustrated in
Although the present invention has been particularly described in conjunction with specific embodiments, it is evident that many alternatives, modifications, and variations will be apparent to those skilled in the art. It is therefore contemplated that the appended claims will embrace any such alternatives, modifications, and variations as falling within the true scope and spirit of the present invention.
Number | Name | Date | Kind |
---|---|---|---|
3561445 | Katerndahl et al. | Feb 1971 | A |
3995628 | Gula et al. | Dec 1976 | A |
4676249 | Arenas et al. | Jun 1987 | A |
4724846 | Evans, III | Feb 1988 | A |
5120308 | Hess | Jun 1992 | A |
5125905 | Wright et al. | Jun 1992 | A |
5190528 | Fonger et al. | Mar 1993 | A |
5273042 | Lynch et al. | Dec 1993 | A |
5279573 | Klosterman | Jan 1994 | A |
5282479 | Havran | Feb 1994 | A |
5312341 | Turi | May 1994 | A |
5366444 | Martin | Nov 1994 | A |
5370609 | Drasler et al. | Dec 1994 | A |
5403338 | Milo | Apr 1995 | A |
5438993 | Lynch et al. | Aug 1995 | A |
5454785 | Smith | Oct 1995 | A |
5484419 | Fleck | Jan 1996 | A |
5507300 | Mukai et al. | Apr 1996 | A |
5730150 | Peppel et al. | Mar 1998 | A |
5785675 | Drasler et al. | Jul 1998 | A |
5810835 | Ryan et al. | Sep 1998 | A |
5827202 | Miraki et al. | Oct 1998 | A |
5871495 | Mueller | Feb 1999 | A |
5895404 | Ruiz | Apr 1999 | A |
5968059 | Ellis et al. | Oct 1999 | A |
5976164 | Bencini et al. | Nov 1999 | A |
5989278 | Mueller | Nov 1999 | A |
6002955 | Willems et al. | Dec 1999 | A |
6011988 | Lynch et al. | Jan 2000 | A |
6045565 | Ellis et al. | Apr 2000 | A |
6059484 | Greive | May 2000 | A |
6063082 | DeVore et al. | May 2000 | A |
6093185 | Ellis et al. | Jul 2000 | A |
6096001 | Drasler et al. | Aug 2000 | A |
6123084 | Jandak et al. | Sep 2000 | A |
6129697 | Drasler et al. | Oct 2000 | A |
6216573 | Moutafis et al. | Apr 2001 | B1 |
6231564 | Gambale | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6258061 | Drasler et al. | Jul 2001 | B1 |
6290709 | Ellis et al. | Sep 2001 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6416490 | Ellis et al. | Jul 2002 | B1 |
6423027 | Gonon | Jul 2002 | B1 |
6423028 | Gonon | Jul 2002 | B1 |
6451017 | Moutafis et al. | Sep 2002 | B1 |
6471683 | Drasler et al. | Oct 2002 | B2 |
6477402 | Lynch et al. | Nov 2002 | B1 |
6511493 | Moutafis et al. | Jan 2003 | B1 |
6537266 | Mottola et al. | Mar 2003 | B1 |
6544209 | Drasler et al. | Apr 2003 | B1 |
6551281 | Raulerson et al. | Apr 2003 | B1 |
6558366 | Drasler et al. | May 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6660003 | DeVore et al. | Dec 2003 | B1 |
6669710 | Moutafis et al. | Dec 2003 | B2 |
6676627 | Bonnette et al. | Jan 2004 | B1 |
6676637 | Bonnette et al. | Jan 2004 | B1 |
6689089 | Tiedtke et al. | Feb 2004 | B1 |
6692456 | Eppstein et al. | Feb 2004 | B1 |
6719718 | Bonnette et al. | Apr 2004 | B2 |
6749617 | Palasis et al. | Jun 2004 | B1 |
6755803 | Le et al. | Jun 2004 | B1 |
6764483 | Bonnette et al. | Jul 2004 | B1 |
6805684 | Bonnette et al. | Oct 2004 | B2 |
6808508 | Zafirelis et al. | Oct 2004 | B1 |
6875193 | Weisel et al. | Apr 2005 | B1 |
6890353 | Cohn et al. | May 2005 | B2 |
6899712 | Moutafis et al. | May 2005 | B2 |
6913605 | Fletcher et al. | Jul 2005 | B2 |
6926726 | Drasler et al. | Aug 2005 | B2 |
6945951 | Bonnette et al. | Sep 2005 | B1 |
6953466 | Palasis et al. | Oct 2005 | B2 |
6984239 | Drasler et al. | Jan 2006 | B1 |
7048733 | Hartley et al. | May 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7083588 | Shmulewitz et al. | Aug 2006 | B1 |
7112197 | Hartley et al. | Sep 2006 | B2 |
20010001124 | Mueller | May 2001 | A1 |
20010051785 | Bonnette et al. | Dec 2001 | A1 |
20010051811 | Bonnette et al. | Dec 2001 | A1 |
20010056257 | Drasler et al. | Dec 2001 | A1 |
20020050197 | Moutafis et al. | May 2002 | A1 |
20020062091 | Jacobsen et al. | May 2002 | A1 |
20020143289 | Ellis et al. | Oct 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020198550 | Nash et al. | Dec 2002 | A1 |
20030009166 | Moutafis et al. | Jan 2003 | A1 |
20030036712 | Heh et al. | Feb 2003 | A1 |
20030040763 | Moutafis et al. | Feb 2003 | A1 |
20030125660 | Moutafis et al. | Jul 2003 | A1 |
20030144657 | Bowe et al. | Jul 2003 | A1 |
20030171735 | Parker et al. | Sep 2003 | A1 |
20040015138 | Currier et al. | Jan 2004 | A1 |
20040039342 | Eppstein et al. | Feb 2004 | A1 |
20040049149 | Drasler et al. | Mar 2004 | A1 |
20040073141 | Hartley et al. | Apr 2004 | A1 |
20040092973 | Chanduszko et al. | May 2004 | A1 |
20040122416 | Schweikert et al. | Jun 2004 | A1 |
20040143262 | Visram et al. | Jul 2004 | A1 |
20040153109 | Tiedtke et al. | Aug 2004 | A1 |
20040193046 | Nash et al. | Sep 2004 | A1 |
20040204672 | Palasis et al. | Oct 2004 | A1 |
20040206365 | Knowlton | Oct 2004 | A1 |
20040210194 | Bonnette et al. | Oct 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040210239 | Nash et al. | Oct 2004 | A1 |
20040230211 | Moutafis et al. | Nov 2004 | A1 |
20040267163 | Opie et al. | Dec 2004 | A1 |
20050033334 | Santra et al. | Feb 2005 | A1 |
20050065507 | Hartley et al. | Mar 2005 | A1 |
20050101984 | Chanduszko et al. | May 2005 | A1 |
20050149097 | Regnell et al. | Jul 2005 | A1 |
20050159738 | Visram et al. | Jul 2005 | A1 |
20050222557 | Baxter et al. | Oct 2005 | A1 |
20050222558 | Baxter et al. | Oct 2005 | A1 |
20050228468 | Macoviak et al. | Oct 2005 | A1 |
20050234436 | Baxter et al. | Oct 2005 | A1 |
20050245847 | Schaeffer | Nov 2005 | A1 |
20050251105 | Peyman | Nov 2005 | A1 |
20050256450 | Palasis et al. | Nov 2005 | A1 |
20050283150 | Moutafis et al. | Dec 2005 | A1 |
20060009715 | Khairkhahan et al. | Jan 2006 | A1 |
20060009737 | Whiting et al. | Jan 2006 | A1 |
20060047267 | Gately et al. | Mar 2006 | A1 |
20060064062 | Gurusamy et al. | Mar 2006 | A1 |
20060064123 | Bonnette et al. | Mar 2006 | A1 |
20060074398 | Whiting et al. | Apr 2006 | A1 |
20060079769 | Whiting et al. | Apr 2006 | A1 |
20060079787 | Whiting et al. | Apr 2006 | A1 |
20060079870 | Barry | Apr 2006 | A1 |
20060095015 | Hobbs et al. | May 2006 | A1 |
20060095052 | Chambers | May 2006 | A1 |
20060122680 | Auth et al. | Jun 2006 | A1 |
20060200113 | Haffner et al. | Sep 2006 | A1 |
20060241648 | Bleich et al. | Oct 2006 | A1 |
20070043307 | Raulerson et al. | Feb 2007 | A1 |
20070185413 | Asai et al. | Aug 2007 | A1 |
20070270741 | Hassett et al. | Nov 2007 | A1 |
Number | Date | Country |
---|---|---|
2212657 | Mar 1998 | CA |
2244596 | Feb 1999 | CA |
2322452 | Sep 1999 | CA |
2499753 | Apr 2004 | CA |
9212575.1 | Nov 1992 | DE |
0470781 | Feb 1992 | EP |
0554754 | Aug 1993 | EP |
0 587 984 | Mar 1994 | EP |
829239 | Mar 1998 | EP |
0 842673 | May 1998 | EP |
0873719 | Oct 1998 | EP |
895752 | Feb 1999 | EP |
1484025 | Dec 2004 | EP |
1570878 | Sep 2005 | EP |
1602339 | Dec 2005 | EP |
1 920795 | May 2008 | EP |
2263407 | Jul 1993 | GB |
10225459 | Aug 1998 | JP |
PA02010065 | Mar 2003 | MX |
WO9324830 | Dec 1993 | WO |
WO9410917 | May 1994 | WO |
WO 9747350 | Dec 1997 | WO |
WO9839038 | Sep 1998 | WO |
WO9922655 | May 1999 | WO |
WO9933510 | Jul 1999 | WO |
WO9944523 | Sep 1999 | WO |
WO9944524 | Sep 1999 | WO |
WO0150966 | Jul 2001 | WO |
WO0178596 | Oct 2001 | WO |
WO 03008005 | Jan 2003 | WO |
WO03045259 | Jun 2003 | WO |
WO03063942 | Aug 2003 | WO |
WO03077733 | Sep 2003 | WO |
WO2004026147 | Apr 2004 | WO |
WO2006060019 | Jun 2006 | WO |
WO2006094222 | Sep 2006 | WO |
WO 2006119503 | Nov 2006 | WO |
WO2005046487 | May 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20090182281 A1 | Jul 2009 | US |